Healthcare
Moderna Inc. (MRNA)
Moderna Inc. stock analysis and opportunity scoring
$137.99
↓ -3.35%
Moderna Inc. (MRNA) at a glance
Moderna Inc. (MRNA) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
MRNA last traded at $54.07 as of 2026-08-29.
MKD Intelligence assigns MRNA a composite opportunity score of 51 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for MRNA is 97 out of 100 (high), where a higher number means greater expected volatility.
Price History
High
$174.38
Low
$53.86
Period
Aug 28 - Jul 24 (26d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Reuters · 23h ago
Focus: Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Reuters · 1d ago
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Reuters · 1d ago
Upcoming Events
Data as of Aug 29
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.